Vaccination with Mage-b DNA induces CD8 T-cell responses at young but not old age in mice with metastatic breast cancer

F. Castro, B. Leal, A. Denny, R. Bahar, S. Lampkin, R. Reddick, S. Lu, Claudia Gravekamp

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background:Elderly individuals react less efficiently to vaccines than do adults, mainly because of T-cell unresponsiveness. In this study, we analysed whether tumour-associated antigen (TAA)-specific CD8 T-cell responses could be induced by vaccination in old mice with metastatic breast cancer.Methods:The effect of pcDNA-3.1- and Listeria-based vaccines, expressing TAA Mage-b, on Mage-b-specific immune responses was tested in spleens and draining lymph nodes (LNs) of mild (4TO7cg) and aggressive (4T1) syngeneic metastatic mouse breast tumour models at young (3 months) and old (20 months) age.Results:Interferon γ and interleukin-2 levels increased significantly in draining LNs and spleens of Mage-b-vaccinated mice compared with those in control groups at young but not old age in both mouse tumour models. A significant increase was observed in the number of IFNγ-producing Mage-b-specific CD8 T cells after Mage-b vaccination in the 4T1 model at young but not old age. This correlated with a reduced protective effect of Mage-b vaccination against metastatic breast cancer at old compared with young age.Conclusions:The absence of CD8 T-cell responses after Mage-b vaccination and the accompanying reduced protection against metastatic breast cancer in old compared with young mice point towards the need for tailoring cancer vaccination to older age.

Original languageEnglish (US)
Pages (from-to)1329-1337
Number of pages9
JournalBritish Journal of Cancer
Volume101
Issue number8
DOIs
StatePublished - Oct 20 2009

Fingerprint

Vaccination
Breast Neoplasms
T-Lymphocytes
DNA
Neoplasm Antigens
Vaccines
Spleen
Lymph Nodes
Listeria
Interferons
Interleukin-2
Neoplasms
Control Groups

Keywords

  • Breast cancer
  • Innate immune system
  • Mage-b DNA vaccine
  • Metastases
  • Old age
  • Young age

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Vaccination with Mage-b DNA induces CD8 T-cell responses at young but not old age in mice with metastatic breast cancer. / Castro, F.; Leal, B.; Denny, A.; Bahar, R.; Lampkin, S.; Reddick, R.; Lu, S.; Gravekamp, Claudia.

In: British Journal of Cancer, Vol. 101, No. 8, 20.10.2009, p. 1329-1337.

Research output: Contribution to journalArticle

Castro, F. ; Leal, B. ; Denny, A. ; Bahar, R. ; Lampkin, S. ; Reddick, R. ; Lu, S. ; Gravekamp, Claudia. / Vaccination with Mage-b DNA induces CD8 T-cell responses at young but not old age in mice with metastatic breast cancer. In: British Journal of Cancer. 2009 ; Vol. 101, No. 8. pp. 1329-1337.
@article{f5f7ea0a66574f2eaceb1e335ac1effa,
title = "Vaccination with Mage-b DNA induces CD8 T-cell responses at young but not old age in mice with metastatic breast cancer",
abstract = "Background:Elderly individuals react less efficiently to vaccines than do adults, mainly because of T-cell unresponsiveness. In this study, we analysed whether tumour-associated antigen (TAA)-specific CD8 T-cell responses could be induced by vaccination in old mice with metastatic breast cancer.Methods:The effect of pcDNA-3.1- and Listeria-based vaccines, expressing TAA Mage-b, on Mage-b-specific immune responses was tested in spleens and draining lymph nodes (LNs) of mild (4TO7cg) and aggressive (4T1) syngeneic metastatic mouse breast tumour models at young (3 months) and old (20 months) age.Results:Interferon γ and interleukin-2 levels increased significantly in draining LNs and spleens of Mage-b-vaccinated mice compared with those in control groups at young but not old age in both mouse tumour models. A significant increase was observed in the number of IFNγ-producing Mage-b-specific CD8 T cells after Mage-b vaccination in the 4T1 model at young but not old age. This correlated with a reduced protective effect of Mage-b vaccination against metastatic breast cancer at old compared with young age.Conclusions:The absence of CD8 T-cell responses after Mage-b vaccination and the accompanying reduced protection against metastatic breast cancer in old compared with young mice point towards the need for tailoring cancer vaccination to older age.",
keywords = "Breast cancer, Innate immune system, Mage-b DNA vaccine, Metastases, Old age, Young age",
author = "F. Castro and B. Leal and A. Denny and R. Bahar and S. Lampkin and R. Reddick and S. Lu and Claudia Gravekamp",
year = "2009",
month = "10",
day = "20",
doi = "10.1038/sj.bjc.6605329",
language = "English (US)",
volume = "101",
pages = "1329--1337",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Vaccination with Mage-b DNA induces CD8 T-cell responses at young but not old age in mice with metastatic breast cancer

AU - Castro, F.

AU - Leal, B.

AU - Denny, A.

AU - Bahar, R.

AU - Lampkin, S.

AU - Reddick, R.

AU - Lu, S.

AU - Gravekamp, Claudia

PY - 2009/10/20

Y1 - 2009/10/20

N2 - Background:Elderly individuals react less efficiently to vaccines than do adults, mainly because of T-cell unresponsiveness. In this study, we analysed whether tumour-associated antigen (TAA)-specific CD8 T-cell responses could be induced by vaccination in old mice with metastatic breast cancer.Methods:The effect of pcDNA-3.1- and Listeria-based vaccines, expressing TAA Mage-b, on Mage-b-specific immune responses was tested in spleens and draining lymph nodes (LNs) of mild (4TO7cg) and aggressive (4T1) syngeneic metastatic mouse breast tumour models at young (3 months) and old (20 months) age.Results:Interferon γ and interleukin-2 levels increased significantly in draining LNs and spleens of Mage-b-vaccinated mice compared with those in control groups at young but not old age in both mouse tumour models. A significant increase was observed in the number of IFNγ-producing Mage-b-specific CD8 T cells after Mage-b vaccination in the 4T1 model at young but not old age. This correlated with a reduced protective effect of Mage-b vaccination against metastatic breast cancer at old compared with young age.Conclusions:The absence of CD8 T-cell responses after Mage-b vaccination and the accompanying reduced protection against metastatic breast cancer in old compared with young mice point towards the need for tailoring cancer vaccination to older age.

AB - Background:Elderly individuals react less efficiently to vaccines than do adults, mainly because of T-cell unresponsiveness. In this study, we analysed whether tumour-associated antigen (TAA)-specific CD8 T-cell responses could be induced by vaccination in old mice with metastatic breast cancer.Methods:The effect of pcDNA-3.1- and Listeria-based vaccines, expressing TAA Mage-b, on Mage-b-specific immune responses was tested in spleens and draining lymph nodes (LNs) of mild (4TO7cg) and aggressive (4T1) syngeneic metastatic mouse breast tumour models at young (3 months) and old (20 months) age.Results:Interferon γ and interleukin-2 levels increased significantly in draining LNs and spleens of Mage-b-vaccinated mice compared with those in control groups at young but not old age in both mouse tumour models. A significant increase was observed in the number of IFNγ-producing Mage-b-specific CD8 T cells after Mage-b vaccination in the 4T1 model at young but not old age. This correlated with a reduced protective effect of Mage-b vaccination against metastatic breast cancer at old compared with young age.Conclusions:The absence of CD8 T-cell responses after Mage-b vaccination and the accompanying reduced protection against metastatic breast cancer in old compared with young mice point towards the need for tailoring cancer vaccination to older age.

KW - Breast cancer

KW - Innate immune system

KW - Mage-b DNA vaccine

KW - Metastases

KW - Old age

KW - Young age

UR - http://www.scopus.com/inward/record.url?scp=70349907077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349907077&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6605329

DO - 10.1038/sj.bjc.6605329

M3 - Article

C2 - 19826426

AN - SCOPUS:70349907077

VL - 101

SP - 1329

EP - 1337

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 8

ER -